Technical Analysis for IPHYF - Innate Pharma

Grade Last Price % Change Price Change
grade C 6.43 2.55% 0.1600
IPHYF closed up 2.55 percent on Thursday, October 17, 2019, on 7.97 times normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical IPHYF trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Slingshot Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for IPHYF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by enhancing the capability of the body's own immune cells to recognize and kill cancer cells.The Company has pioneered the development of antibodies that block inhibitory checkpoint receptors on NK cells. Today, Innate Pharma has three first-in-class antibodies in clinical development in immuno-oncology and a pipeline of preclinical candidates to novel targets and mechanisms.Its innovative approach has translated into alliances with leaders in the biopharmaceutical industry such as AstraZeneca, Bristol-Myers Squibb, Novo Nordisk A/S and Sanofi.Based in Marseille, France, Innate Pharma had 122 employees as at March 31, 2016. The company is listed on Euronext Paris.
Cancer Life Sciences Antibodies Immune System Cancer Immunotherapy Cancer Treatment Astrazeneca Bristol Myers Squibb Sanofi Biopharmaceutical Industry
Is IPHYF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.71
52 Week Low 4.92
Average Volume 1,286
200-Day Moving Average 7.0572
50-Day Moving Average 6.9342
20-Day Moving Average 7.1958
10-Day Moving Average 7.0337
Average True Range 0.3716
ADX 18.18
+DI 51.015
-DI 37.2083
Chandelier Exit (Long, 3 ATRs ) 7.005199999999999
Chandelier Exit (Short, 3 ATRs ) 7.1548
Upper Bollinger Band 8.4639
Lower Bollinger Band 5.9277
Percent B (%b) 0.2
BandWidth 35.24556
MACD Line -0.1088
MACD Signal Line 0.0518
MACD Histogram -0.1606
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.9650
Resistance 3 (R3) 9.2467 8.6833 8.5425
Resistance 2 (R2) 8.6833 8.0378 8.5425 8.4016
Resistance 1 (R1) 7.5567 7.6389 7.2750 7.2750 8.2608
Pivot Point 6.9933 6.9933 6.8525 6.8525 6.9933
Support 1 (S1) 5.8667 6.3478 5.5850 5.5850 4.5992
Support 2 (S2) 5.3033 5.9489 5.1625 4.4584
Support 3 (S3) 4.1767 5.3033 4.3175
Support 4 (S4) 3.8950